IXHL Incannex Healthcare Inc. - Common Stock
$3,58
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 15, 2026
Zakres 52 tyg.
$0–$6
54% of range
Ocena Analityków
—
Cena Docelowa
—
P/E (TTM)
-0.2
ROE
-653.3%
Marża Zysku Netto
-54517.4%
IXHL Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.58
Kapitalizacja Rynkowa
$42M
P/E (TTM)
-0.2
EPS (TTM)
$-1.35
Przychody (TTM)
$86.0K
Stopa dywidendy
—
ROE
-653.3%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $6
IXHL Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$86.0K
2024-06-30
→
2025-06-30
EPS
$-1.35
2023-06-30
→
2025-06-30
Wolny przepływ pieniężny
$-13M
2024-06-30
→
2025-06-30
Marże
-54517.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
IXHL
Mediana porównawcza
P/E (TTM)
-0.2
4.1
P/S (TTM)
488.2
5.8
P/B
3.1
2.6
Price / FCF (Cena / FCF)
-3.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
IXHL
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-27661.6%
—
Net Profit Margin (Marża Zysku Netto)
-54517.4%
-165.8%
ROA
-250.1%
-59.0%
ROE
-653.3%
-73.5%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
IXHL
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
2.9
3.5
Quick Ratio (Wskaźnik Szybkości)
2.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
IXHL
Mediana porównawcza
Revenue YoY (Przychody R/R)
616.7%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
IXHL
Mediana porównawcza
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-30.5%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 września 2026 | $-11.23 | $-0.94 | — |
| 31 marca 2026 | $-11.23 | $-0.94 | -10.3% |
| 31 grudnia 2025 | $-0.60 | $-0.94 | 0.34% |
| 30 września 2025 | $-0.60 | $-0.94 | 0.34% |
| 30 czerwca 2025 | $-15.30 | $-89.29 | 74.0% |
| 31 marca 2025 | $-238.98 | $-22.16 | -216.8% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $86.0K | $12.0K | |
| R&D Expense | $11M | $13M | |
| SG&A Expense | $13M | $17M | |
| Operating Expenses | $24M | $30M | |
| Operating Income | $-24M | $-30M | |
| Interest Income | $62.0K | $206.0K | |
| Other Non-op | $-23M | $12M | |
| Pretax Income | $-47M | $-18M | |
| Income Tax | · | $30.0K | |
| Net Income | $-47M | $-18M | |
| EPS (Basic) | $-1.35 | $-1.15 | |
| EPS (Diluted) | $-1.35 | $-1.15 | |
| Shares (Basic) | 34,454,269 | 16,164,338 | |
| Shares (Diluted) | 34,454,269 | 16,164,338 | |
| EBITDA | $-24M | $-30M |
Bilans 19
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $6M | |
| Prepaid Expense | $791.0K | $507.0K | |
| Current Assets | $20M | $16M | |
| PP&E (Net) | $227.0K | $472.0K | |
| PP&E (Gross) | $495.0K | $598.0K | |
| Accum. Depreciation | $269.0K | $126.0K | |
| Total Assets | $20M | $17M | |
| Accounts Payable | · | $5M | |
| Accrued Liabilities | $661.0K | $5M | |
| Current Liabilities | $7M | $6M | |
| Capital Leases | $74.0K | $210.0K | |
| Total Liabilities | $7M | $6M | |
| Common Stock | $20.0K | $2.0K | |
| Paid-in Capital | $174M | $125M | |
| Retained Earnings | $-158M | $-111M | |
| AOCI | $-3M | $-3M | |
| Stockholders' Equity | $13M | $11M | |
| Liabilities + Equity | $20M | $17M | |
| Shares Outstanding | 6,479,333 | 17,642,832 |
Przepływy pieniężne 9
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $246.0K | $103.0K | |
| Stock-based Comp | $3M | $9M | |
| Operating Cash Flow | $-13M | $-16M | |
| CapEx | $8.0K | $277.0K | |
| Investing Cash Flow | $-8.0K | $-277.0K | |
| Stock Issued | $48M | · | |
| Net Stock Activity | $48M | · | |
| Financing Cash Flow | $21M | · | |
| Free Cash Flow | $-13M | $-16M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -27661.6% | -250341.7% | |
| Net Margin | -54517.4% | -153825.0% | |
| Pretax Margin | -54517.4% | -153575.0% | |
| EBITDA Margin | -27661.6% | -250341.7% | |
| ROA | -250.1% | -90.4% | |
| ROE | -653.3% | -122.7% | |
| ROIC | · | -268.2% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.9 | 2.9 | |
| Quick Ratio | 2.2 | 1.0 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 616.7% | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $86.0K | $12.0K | |
| Net Income TTM | $-47M | $-18M | |
| Market Cap | $42M | $47M | |
| P/E | -0.2 | -2.6 | |
| P/S | 488.2 | 3888.9 | |
| P/B | 3.1 | 4.2 | |
| P / Tangible Book | 3.1 | 4.2 | |
| P / Cash Flow | -3.4 | -2.9 | |
| P / FCF | -3.4 | -2.9 | |
| Earnings Yield | -625.0% | -39.1% |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | · | $12.0K | $74.0K | |
| R&D Expense | $321.0K | $2M | $1M | $4M | $3M | $1M | $3M | |
| SG&A Expense | $4M | $5M | $6M | $4M | $2M | $4M | $3M | |
| Operating Expenses | $4M | $7M | $7M | $8M | $5M | $5M | $6M | |
| Operating Income | $-4M | $-7M | $-7M | $-8M | $-5M | $-5M | $-6M | |
| Interest Income | · | · | · | $2.0K | $4.0K | $28.0K | $28.0K | |
| Other Non-op | $165.0K | $474.0K | $387.0K | $-24M | $1M | $-890.0K | $834.0K | |
| Pretax Income | $-4M | $-7M | $-6M | $-32M | $-4M | $-6M | $-5M | |
| Net Income | $-4M | $-7M | $-6M | $-32M | $-4M | $-6M | $-5M | |
| EPS (Basic) | $-0.35 | $-0.02 | $-0.02 | $-0.53 | $-6.19 | $-0.33 | $-0.29 | |
| EPS (Diluted) | $-0.35 | $-0.02 | $-0.02 | $-0.53 | $-6.19 | $-0.33 | $-0.29 | |
| Shares (Basic) | 12,348,460 | 349,464,317 | 310,309,659 | -20,445,524 | 654,418 | 17,624,422 | 17,642,832 | |
| Shares (Diluted) | 12,348,460 | 349,464,317 | 310,309,659 | -20,445,524 | 654,418 | 17,624,422 | 17,642,832 | |
| EBITDA | $-4M | $-7M | $-7M | · | $-5M | $-5M | $-6M |
Bilans 21
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $69M | $73M | $15M | $7M | $2M | $4M | |
| Prepaid Expense | $405.0K | $431.0K | $486.0K | $791.0K | $416.0K | $417.0K | $489.0K | |
| Current Assets | $80M | $75M | $78M | $20M | $16M | $11M | $15M | |
| PP&E (Net) | $47.0K | $108.0K | $168.0K | $227.0K | $277.0K | $273.0K | $428.0K | |
| PP&E (Gross) | $572.0K | $506.0K | $503.0K | $495.0K | $597.0K | $560.0K | $625.0K | |
| Accum. Depreciation | $525.0K | $398.0K | $335.0K | $269.0K | $320.0K | $287.0K | $197.0K | |
| Total Assets | $80M | $75M | $79M | $20M | $16M | $11M | $16M | |
| Accrued Liabilities | $202.0K | $133.0K | $154.0K | $661.0K | $4M | $3M | $7M | |
| Short-term Debt | · | · | · | · | $1M | $1M | · | |
| Current Liabilities | $2M | $2M | $2M | $7M | $7M | $6M | $9M | |
| Capital Leases | $42.0K | $53.0K | $64.0K | $74.0K | $104.0K | $152.0K | $221.0K | |
| Total Liabilities | $5M | $2M | $2M | $7M | $9M | $10M | $9M | |
| Long-term Debt | · | · | · | · | · | $2M | · | |
| Total Debt | · | · | · | · | $1M | $4M | · | |
| Common Stock | $41.0K | $36.0K | $35.0K | $20.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $253M | $247M | $244M | $174M | $137M | $126M | $126M | |
| Retained Earnings | $-174M | $-170M | $-164M | $-158M | $-126M | $-122M | $-116M | |
| AOCI | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Stockholders' Equity | $75M | $73M | $77M | $13M | $7M | $965.0K | $7M | |
| Liabilities + Equity | $80M | $75M | $79M | $20M | $16M | $11M | $16M | |
| Shares Outstanding | 13,683,121 | 359,218,871 | 347,705,507 | 194,379,996 | 17,785,235 | 17,785,235 | 17,642,832 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $65.0K | $59.0K | $66.0K | $61.0K | $-5.0K | $126.0K | $64.0K | |
| Stock-based Comp | $1M | $2M | $3M | $1M | $417.0K | $435.0K | $459.0K | |
| Operating Cash Flow | $-2M | $-5M | $-9M | $-1M | $-3M | $-6M | $-2M | |
| CapEx | $5.0K | $4.0K | $2.0K | $0 | $0 | · | · | |
| Investing Cash Flow | $-18.0K | $-4.0K | $-42.0K | $0 | $0 | · | · | |
| Stock Issued | $7M | $2M | $69M | $36M | · | · | · | |
| Stock Repurchased | $1M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $69M | · | · | · | · | |
| Financing Cash Flow | $5M | $927.0K | $67M | $10M | $8M | $4M | · | |
| Net Change in Cash | · | · | · | · | · | · | $-2M | |
| Free Cash Flow | · | · | $-9M | · | · | · | · |
Rentowność 6
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -41700.0% | -8451.3% | |
| Net Margin | · | · | · | · | · | -49116.7% | -7324.3% | |
| Pretax Margin | · | · | · | · | · | -49116.7% | -7324.3% | |
| EBITDA Margin | · | · | · | · | · | -41700.0% | -8451.3% | |
| ROA | -8.1% | -15.2% | -13.5% | · | -23.7% | -35.2% | -67.5% | |
| ROE | -9.4% | -17.5% | -15.3% | · | -36.8% | -59.4% | -164.4% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 41.6 | 48.3 | 47.5 | · | 2.1 | 1.8 | 1.6 | |
| Quick Ratio | 38.6 | 44.5 | 44.5 | · | 0.9 | 0.4 | 0.4 | |
| Debt / Equity | · | · | · | · | 0.2 | 3.9 | · | |
| LT Debt / Equity | · | · | · | · | · | 2.5 | · |
Efektywność 1
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-21M | $-23M | $-22M | · | $-21M | $-23M | $-17M | |
| Market Cap | $41M | $129M | $161M | · | $12M | $38M | $35M | |
| Enterprise Value | · | · | · | · | $7M | $39M | · | |
| P/E | -0.5 | -0.6 | -0.6 | · | -0.6 | -1.6 | -1.8 | |
| P/B | 0.5 | 1.8 | 2.1 | · | 1.6 | 39.1 | 5.3 | |
| P / Tangible Book | 0.5 | 1.8 | 2.1 | · | 1.6 | 39.1 | 5.3 | |
| P / Cash Flow | · | · | -17.6 | · | · | · | -16.0 | |
| P / FCF | · | · | -17.6 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | -1.3 | -7.9 | · | |
| Earnings Yield | -219.3% | -159.2% | -181.0% | · | -177.2% | -62.7% | -54.3% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Przychody | $86.0K | $12.0K | — |
| Marża Operacyjna % | -27661.6% | -250341.7% | — |
| Zysk netto | $-47M | $-18M | $-49M |
| Rozwodniony EPS | $-1.35 | $-1.15 | $-3.32 |
Bilans
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Wskaźnik bieżący | 2.9 | 2.9 | — |
| Wskaźnik Szybkości | 2.2 | 1.0 | — |
Przepływy pieniężne
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Wolny przepływ pieniężny | $-13M | $-16M | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.